SCHEMBL14160106

SCHEMBL14160106

Bc1cc(CN2CCN(c3ccc(N)c(C(F)(F)F)c3)CC2)ccc1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.50
▸ ALDH1A1 P00352 5/20 0.50
▸ NPSR1 Q6W5P4 2/20 0.50
▸ DRD2 P14416 3/20 0.45
▸ DRD4 P21917 3/20 0.45
▸ DRD3 P35462 3/20 0.45
▸ ALOX15 P16050 2/20 0.44
▸ TSHR P16473 2/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ MAPT P10636 1/20 0.42
▸ PPARD Q03181 1/20 0.42
▸ PPARA Q07869 1/20 0.42
▸ LMNA P02545 3/20 0.42
▸ USP2 O75604 1/20 0.42
▸ THRB P10828 1/20 0.42
▸ TP53 P04637 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4711818 0.78 DRD2 (0.58) KDM4EALDH1A1NPSR1DRD2DRD4
SCHEMBL4710340 0.76 PPARD (0.52) KDM4EALDH1A1NPSR1DRD2DRD4
SCHEMBL4710392 0.75 HTT (0.52) KDM4EALDH1A1NPSR1DRD2DRD4
SCHEMBL14160136 0.74 DRD2 (0.56) KDM4EALDH1A1NPSR1DRD2DRD4
SCHEMBL11181299 0.73 LMNA (0.64) KDM4EALDH1A1NPSR1DRD2DRD4
SCHEMBL4709107 0.73 LMNA (0.55) KDM4EALDH1A1NPSR1DRD2DRD4
Hydrochloric Acid SCHEMBL11187904 0.72 LMNA (0.62) KDM4EALDH1A1NPSR1DRD2DRD4
SCHEMBL13067685 0.72 NR1H2 (0.58) KDM4EALDH1A1MAPTLMNAMEN1
SCHEMBL29998844 0.72 NR1H2 (0.58) KDM4EALDH1A1MAPTLMNAMEN1
SCHEMBL30340643 0.70 GAA (0.61) KDM4EALDH1A1SMN1; SMN2MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1935885-A2 Melanin concentrating hormone receptor ligands : substituted 1-benzyl-4-aryl piperazine analogues. NEUROGEN CORPORATION (US) 2008-06-25 — — EP disclosed
Send feedback